Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.25
Bid: 34.25
Ask: 35.45
Change: -1.075 (-2.99%)
Spread: 1.20 (3.504%)
Open: 36.00
High: 36.00
Low: 34.00
Prev. Close: 35.925
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: H&T Group, China Medical, Fyffes...

Wed, 13th May 2009 09:20

Pawnbroker H&T Group said it has traded "significantly" ahead of expectations for the year to date. It also said it was positive about prospects for the current year but remains conscious of the current difficult economic climate."The principal reason for the strong performance is the sustained gold price which has benefitted the Group's retail sales, auctions, scrap and gold purchases. The Group is also pleased with the continuing success of the store expansion programme," said H&T.Chinese pharmaceutical sales, marketing & research firm China Medical saw pre-tax profit rise to $19.5m from $10.3m before on sales 40% to $72.6m. Total dividend for year will be $0.15p share against $0.10p each. "I am delighted to report on a second outstanding year for CMS as a public company despite the challenging economic environment seen domestically and globally. We have achieved sustained and steady growth in sales and profits, and I am pleased that," said the group.Fruit importer and distributor Fyffes said trading in teh year to date has been in line with expectations and it remains on course to achieve its earnings target for the year. Previously it has taargeted an adjusted EVIB for 2009 in the range of €14m-€18m. Shares in Futura Medical fell back after the consumer healthcare products firm reported a delay in achieving regulatory approval for CSD500, a condom designed to help men maintain an erection.Futura, which is developing the condom with Durex firm SSL, hoped the product would be awarded a CE mark soon after EU authorities expressed a positive opinion on the product's pharmaceutical aspects. However, SSL's decision to move condom manufacturing to Asia means the EU has asked for additional manufacturing data on CSD500 and Futura now expects to receive CE marketing authorisation around the end of the year.Public sector focused support services company Tribal said trading in 2009 has been in line with expectations.The sales pipeline remains healthy while committed income now stands at £210m, up from £139m at the beginning of the year. Printing group Communisis shot up after it announced a contract to T-Mobile UK 's marketing division with a suite of printing services. The contract was awarded to Communisis following a tender process. Housebuilder McInerney said trading conditions during 2009 in its key markets of Ireland and UK continue to be challenging due to low consumer confidence, restricted access to mortgages and the uncertain financial climate."We remain focused on generating positive cash flow and the implementation of additional efficiencies in the Group's cost base. Management's key objective is to rebuild shareholder value in the medium term," it said.Shares in Rheochem slipped back down again today after the oil and gas firm released a statement saying it knew of no reason behind its sudden share price rise earlier in the day. The group said the strategic review of its oil and gas assets are still ongoing and no decision has been reached.
More News
5 Sep 2018 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 6 September PPHE Hotel GroupHalf Year ResultsHunters PropertyHalf Year Year Year

Read more
18 Jun 2018 13:25

European Wealth Appoints Jonathan Freeman As Non-Executive Director

LONDON (Alliance News) - European Wealth Group Ltd said Monday it appointed Jonathan Freeman as non-executive director.Freeman currently holds the roles of non-executive chairman of LED of

Read more
13 Jun 2018 12:36

Futura Says Licensing Of Erectile Dysfunction Gel Remains Top Priority

LONDON (Alliance News) - Futura Medical PLC Chairman John Clarke said Wednesday the company continues to make "good progress" both in product development and commercialisation.In

Read more
26 Apr 2018 13:53

Futura Medical Begins Groundwork For MED 2002 Phase III Trial

LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Thursday it has started preparing for a phase III trial for its proposed erectile dysfunction gel MED 2002.This trial what a

Read more
14 Mar 2018 16:08

Futura Medical Annual Loss Widens On Higher Research Costs

LONDON (Alliance News) - Futura Medical PLC said Wednesday that planned increase in research and development expenditure for the development of erectile dysfunction gel has in

Read more
10 Jan 2017 11:05

Futura Medical signs license agreement with Thornton & Ross

(ShareCast News) - Futura Medical, an AIM listed innovative healthcare company focused on transdermal technology, has signed a licensing agreement with Thornton & Ross for the commercialisation of TPR100, the company's novel diclofenac gel for pain relief. Thornton & Ross (T&R) is one of the largest

Read more
16 Nov 2016 09:28

Futura To Develop Two Dose Strengths Of Erectile Dysfunction Gel

Read more
27 Oct 2016 14:24

Futura Medical partner approved for erectogenic condom manufacture

(ShareCast News) - Advanced transdermal technology-focused healthcare company Futura Medical announced on Thursday that, as anticipated, its regulatory submission to allow TTK Protective Devices to manufacture its erectogenic condom, CSD500, has been approved by the relevant EU Notified Body with an

Read more
27 Oct 2016 08:11

Futura Medical To Raise Up To GBP12 Million To Speed Up Products (ALLISS)

Read more
7 Sep 2016 10:35

Futura Medical perks up on 'breakthrough' erectile dysfunction study

(ShareCast News) - Shares in AIM-listed Futura Medical perked up to a two-year high as the company revealed that trials of its erectile dysfunction (ED) treatment had found it to be effective, safe and with the potential to be the fastest-acting product on the market. A clinical study of Futura's ME

Read more
7 Sep 2016 07:25

LONDON BRIEFING: Change At Top For Well-Performing Hargreaves Lansdown

Read more
7 Sep 2016 07:11

Futura Medical Gets Positive Results On Erectile Dysfunction Gel

Read more
21 Jun 2016 07:11

Futura Medical Sees "Clear Potential For Value Generation This Year"

Read more
20 Jun 2016 07:26

Futura Medical Signs Southeast Europe Distribution Deal For Condom

Read more
14 Jun 2016 15:02

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.